Quality of Life Improvement During Chemotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorChristian Schwegler

About this trial

This study is a randomized controlled trial, taking place at the University Hospital Basel (CH). It aims at the alleviation of breast cancer patients' life quality during chemotherapy.

The intervention group will participate in 10 sessions of structured hypnotherapy during the course of chemotherapy in addition to the standard of care. The control group will have access to the standard of care without any additional treatment. The main goal of the study is to investigate whether quality of life is higher among patients in the intervention group. Additionally, it will be analyzed if the interventions have a positive effect on chemotherapy side effects, symptoms of anxiety and depression and the immune system. Finally, the relative dose intensity (RDI) as well as treatment schedule adherence will be assessed.

There are no risks to be expected from the intervention itself. In the case of positive findings, the standard of psycho-oncological care can be updated by integrating structured hypnotherapeutic interventions into the treatment of patients with breast cancer.

Eligibility criteria

Qualifiers

Minimum Age 18 years

Female

Primary breast cancer

Receiving neo-adjuvant or adjuvant chemotherapy

Disqualifiers

Verbal or cognitive deficits that are not compatible with outpatient psychotherapy

Not consenting patients and vulnerable persons

Psychological disorders that prevent patients from participating in the study (e.g. psychotic disorder)

acute suicidality

Trial design

Treatments tested in this trial

  • Structured Hypnotherapy

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Christian Schwegler

Lead sponsor

University Hospital, Basel, Switzerland

Sponsor institution